Biopharmaceutical evaluation of the liposomes prepared by rehydration of freeze-dried empty liposomes (FDELs) with an aqueous solution of a drug.
We have evaluated a method for preparation of a dispersion of liposomes encapsulating a drug, namely rehydration of freeze-dried empty (not containing drug) liposomes with an aqueous drug solution (FDEL method). In the present study, we characterized and compared this method with the conventional method using a lipid composition of DPPC-DPPG-cholesterol in a molar ratio of 27:3:20. Two hydrophilic compounds, [3H]-inulin and [3H]-mannitol, were used as model drugs. Liposomal preparations by the FDEL method had an encapsulation efficiency of 2.9 and 6.7% for [3H]-inulin and [3H]-mannitol, respectively, when rehydrated and incubated at 70 degrees C. Since non-specific adsorption of these markers to liposomal membrane is negligible, this method produces liposomes which encapsulate a drug in the intravesicular space. One-tenth of the marker encapsulated in the liposomes prepared by the FDEL method (F-liposomes) was released very rapidly on incubation with rat plasma, followed by the slow release of the remaining fraction thereafter. No such rapid-release phase was observed for the liposomes prepared by the conventional method (C-liposomes). This suggests the existence of two types of encapsulation, loose encapsulation and tight encapsulation, in F-liposomes at least. Pharmacokinetic parameters of marker encapsulated tightly in F-liposomes were comparable to those in C-liposomes. It is likely that amphipathic drugs such as doxorubicin are incorporated into liposomes more easily than inulin and mannitol when formulated by the FDEL method. These results therefore suggest that the FDEL method is useful in the preparation of a liposomal formulation of a drug.
Basic Technology Research Laboratory, Daiichi Pharmaceutical Co., Ltd., Tokyo, Japan.
K
K
Yachi
H
H
Harashima
H
H
Kikuchi
R
R
Sudo
H
H
Yamauchi
K
K
Ebihara
H
H
Matsuo
K
K
Funato
H
H
Kiwada
D015060:1,2-Dipalmitoylphosphatidylcholine / Q000008:administration & dosage / Q000493:pharmacokinetics; D000818:Animals; D019540:Area Under Curve; D001702:Biopharmaceutics; D004234:Diuretics, Osmotic / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D004337:Drug Carriers; D004355:Drug Stability; D005069:Evaluation Studies as Topic; D005440:Fluid Therapy; D005612:Freeze Drying / Q000379:methods; D007275:Injections, Intravenous; D007444:Inulin / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D008081:Liposomes; D008297:Male; D008353:Mannitol / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D010316:Particle Size; D051381:Rats; D017208:Rats, Wistar; D012996:Solutions; D014018:Tissue Distribution
D004234:Diuretics, Osmotic; D004337:Drug Carriers; D008081:Liposomes; D012996:Solutions; D015060:1,2-Dipalmitoylphosphatidylcholine; D008353:Mannitol; D007444:Inulin